FundedIQ
Biotechnology

Aralez Bio: Funding, Investors & Team (Oct 2026)

We have invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Our proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct. To learn more, visit us at www.aralezbio.com Aralez Bio is a proud member of Cyclotron Road.

aralezbio.com LinkedIn Emeryville, United States 11-50 employees
Biotechnology Chemical Engineering Medical
Total raised
$12.0M
Rounds
1
Latest
Series A
Oct 2024

Aralez Bio has raised $12.0M across 1 funding round on record, the most recent a Series A of $12.0M announced in Oct 2024.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Aralez Bio Company Profile and Key Stats

Total funding raised
$12.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$12.0M in Oct 2024
Employees
11-50
reported band
Headquarters
Emeryville, United States

Latest funding round on record: Oct 2024.

Aralez Bio Funding Rounds

Date
Round
Amount
Series A
$12.0M

Aralez Bio Founders and Leadership Team

Name
Role
Contact
David Romney
Founder
Locked

Contact details for the Aralez Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Aralez Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Aralez Bio's latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Aralez Bio in Biotechnology and Emeryville

Companies Similar to Aralez Bio

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Aralez Bio Funding FAQs

What does Aralez Bio do?

We have invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Our proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct. To learn more, visit us at www.aralezbio.com Aralez Bio is a proud member of Cyclotron Road.

How much funding has Aralez Bio raised?

Aralez Bio has raised $12.0M across 1 round on record. The most recent is a Series A of $12.0M announced in Oct 2024.

When did Aralez Bio last raise funding?

Aralez Bio's most recent funding round on record is a Series A of $12.0M, announced in Oct 2024.

Who founded Aralez Bio?

FundedIQ lists David Romney (Founder) at Aralez Bio.

Where is Aralez Bio headquartered?

Aralez Bio is based in Emeryville, California, United States.

How many employees does Aralez Bio have?

Aralez Bio is in the 11-50 employee band.

How does Aralez Bio's funding compare to other Biotechnology startups?

Aralez Bio's latest round of $12.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Aralez Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aralez Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.